Recombinant Human Injection 4000 IU

Get a Price/Quote

MOQ : 10 Units

Recombinant Human Injection 4000 IU Specification

Dosage Form
Injection

Indication
Treatment of anemia in chronic renal failure, chemotherapy-induced anemia, anemia in HIV-infected patients, and to reduce allogeneic blood transfusion in surgery patients

Salt Composition
Recombinant Human Erythropoietin Alfa (4000 IU) - rHuEPO

Enzyme Types
Glycoprotein hormone cytokine (not a true enzyme but has biological activity similar to endogenous erythropoietin)

Feature
Free from human proteins, low immunogenicity, batch-to-batch consistency

Ingredients
Recombinant human erythropoietin alfa, excipients, solvent for injection

Application
Medical, Hospital, Clinical use (parenteral)

Ph Level
Approximately 6.5-7.0

Temperature Needed For Fermentation
36-37C (during cell culture/production phase)

Physical Color/Texture
Clear, colorless or slightly yellow liquid

Fermentation Smell
Odorless (final injection preparation)

Enzymatic Activity
Stimulates erythropoiesis (red blood cell production)

Storage Instructions
Dry place

Shelf Life
24 months from date of manufacture

Administration Route
Subcutaneous or intravenous

Side Effects
Possible headache, hypertension, injection site reactions, flu-like symptoms

Contraindications
Uncontrolled hypertension, hypersensitivity to rHuEPO or excipients

Packaging Type
Pre-filled syringe / Ampoule

Warnings & Precautions
Monitor hemoglobin levels regularly, use under medical supervision

Preservative
Preservative free, single-use only

Compatibility
Do not mix with other medications

Strength
4000 IU/0.4 mL

Regulatory Status
Prescription only (Rx), complies with regulatory authorities

Recombinant Human Injection 4000 IU Trade Information

Minimum Order Quantity
10 Units

Payment Terms
Cash Advance (CA)

Supply Ability
5000 Units Per Month

Delivery Time
5-7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

About Recombinant Human Injection 4000 IU

Experience the top-rated Recombinant Human Injection 4000 IU, a masterpiece in anemia management for chronic renal failure, chemotherapy, and surgical patients. This champion solution comes in a pre-filled syringe or ampoule, ensuring savings through efficient, single-use administration, either subcutaneously or intravenously. Terrific for hospital, clinical, and medical applications, this formulation is preservative-free, has batch-to-batch consistency, and contains no human proteins-reducing immunogenicity. Monitor closely under medical supervision, store in a dry place, and trust this top choice regulatorily approved for prescription-only use. Do not mix with other medications.

Versatile Medical Application and Ease of Use

Recombinant Human Injection 4000 IU is designed for parenteral use in diverse clinical environments, including hospitals, medical centers, and outpatient clinics. Its top-notch application surfaces include subcutaneous and intravenous administration, making it highly adaptable for treating anemia across various patient groups. Featuring a clear, colorless or slightly yellow appearance, it is supplied ready-to-use, promising convenience for health professionals and patients alike.

Sample Access, Arrival, and Sale Pricing Policy

A sample of Recombinant Human Injection 4000 IU is available for evaluation. Expect swift arrival and competitive sale rates tailored for hospital and clinical needs. The sample policy is straightforward: available upon request, allowing users to review quality and compatibility before making purchasing decisions. Swift deliveries and transparent pricing underscore our commitment to superior service and customer satisfaction in hospital, clinical, and laboratory settings.

FAQ's of Recombinant Human Injection 4000 IU:

Q: How should Recombinant Human Injection 4000 IU be administered?

A: It can be administered either subcutaneously or intravenously as instructed by a healthcare professional. The injection should be used as a single-use only and never mixed with other medications.

Q: What is the main benefit of using this injection for anemia?

A: This injection stimulates erythropoiesis (red blood cell production), or similar to natural erythropoietin, helping to effectively manage anemia in patients with chronic renal failure, those undergoing chemotherapy, and applicable surgical cases.

Q: When should this injection not be used?

A: It should not be used in patients with uncontrolled hypertension or hypersensitivity to recombinant human erythropoietin alfa or any of its excipients. Always check contraindications with your doctor.

Q: Where should Recombinant Human Injection 4000 IU be stored?

A: Store the product in a dry place, as specified in the storage instructions. Avoid exposure to extreme temperatures and check the product packaging for further details.

Q: What is the process for obtaining a sample and what about delivery times?

A: Samples are available upon request. Once ordered, you can expect timely arrival and reliable delivery. The rate and eventual sale price will be communicated transparently as part of our sample policy.

Q: How often should patients on this injection have their hemoglobin levels monitored?

A: Regular monitoring of hemoglobin levels is essential for patients utilizing Recombinant Human Injection 4000 IU. Consult your healthcare provider for a tailored monitoring schedule based on your individual treatment plan.

Tell us about your requirement